Programme du congrès

Lieu : Online

Langue : ENG

Date de début : 19/10/2021

Date de fin : 21/10/2021

https://til-therapies.com/take-part/register/?utm_source=external&utm_medium=event-listing&utm_campaign=event-listing&utm_content=media-partner/evvnt/paid/em-01/ev-20998

Spécialités : Santé Publique Et Médecine Sociale

TIL therapies are returning to the forefront of solid tumor treatment to take advantage of their inherent ability to target heterogeneous antigens and survive in the hostile tumor microenvironment. Now with advances in TIL selection through the benchmarking of optimal biomarkers, streamlined manufacturing processes to improve turnaround time and cost of goods, and commercialization discussions on the horizon... it is time to get caught up to speed on the fast-evolving TIL approach.